GLP-1 RAs are synthetic analogues engineered for prolonged receptor engagement
Eventually, it prompts a more substantial production of the peptide hormone
We cant say that GLP-1s are actually causing these symptoms, notes Neil Sehgal, the studys first author and a doctoral student in CIS advised by Guntuku and Ungar
Food and Drug Administration (FDA) hasnt approved any weight loss patches that work like the blockbuster injected GLP-1 drugs Ozempic, Wegovy, Zepbound, and Mounjaro, says Jody Dushay, MD, an assistant professor at Harvard Medical School and an endocrinologist at Beth Israel Deaconess Medical Center in Boston
Thus, substitution of (replacing rather than adding) an agent with cardiorenal benefit might be appropriate if people are at or near A1c target
Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats